Determination of Bioavailability and Clearance of Lamotrigine-XR by a Stable Isotope Technique.
Phase of Trial: Phase I/II
Latest Information Update: 28 Jan 2016
At a glance
- Drugs Lamotrigine (Primary)
- Indications Bipolar depression; Epilepsy; Seizures
- Focus Pharmacokinetics
- 19 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Mar 2010 Planned end date changed from 1 May 2009 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 03 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.